It is well known that the process of drug metabolism affect drug therapeutic and toxic effects. The change of the compatibility of traditional Chinese medicines may lead directly to the change of the metabolism of drug effectiveness in human body. Therefore, the investigation of the metabolism of compound Chinese recipes by modern analytical techniques may play important roles in explanation of the functional mechanisms and compatibility principles of compound Chinese prescriptions.
It is well known that the process of drug metabolism affect drug therapeutic and toxic effects. The change of the compatibility of traditional Chinese medicines may lead directly to the change of the metabolism of drug effectiveness in human body. Therefore, the investigation of the metabolism of compound Chinese recipes by modern analytical techniques may play important roles in explanation of the functional mechanisms and compatibility principles of compound Chinese prescriptions. 1) Few studies were performed to investigate the influence of compatibility on metabolism of compound traditional Chinese prescriptions.
The compound Shuang-Huang-Lian (SHL) recipe is officially recorded in Pharmacopoeia of China, 2) and has the efficiency of removing toxic heat and inducing diaphoresis. It is commonly used for treating acute upper respiratory tract infection, acute bronchitis and light pneumonia.
2) SHL is composed of three herbs: Flos lonicerae, Radix scutellariae and Fructus forsythiae. Baicalin is the main active ingredient in Radix scutellariae (RS) but does not exist in Flos lonicerae and Fructus forsythiae. There are some investigations on the metabolites of baicalin. For example, in vivo metabolism in rat bile, 3) in human urine 4) after taking baicalin orally and in human plasma 5) after intragastrically (i.g.) taking compound prescription Sho-Kaiko-To, in vitro metabolism by human intestinal flora, 6, 7) this study was designed to compare the metabolites of baicalin in rats after oral administration of SHL and single herb RS, and try to explore the principle of SHL compatibility.
Shuang-Huang-Lian (SHL) is a traditional Chinese formula containing Flos lonicerae, Radix scutellariae (RS) and Fructus forsythiae, and is commonly used for treating acute upper respiratory tract infection, acute bronchitis and light pneumonia. The aim of the present study is to compare the metabolites of baicalin in rats when orally administered with SHL and Radix scutellariae, and try to explore the principle of SHL compatibility. By using LC-MS n and HPLC-DAD, the metabolites of baicalin were analyzed from bile, urine and feces of rats dosed with SHL and RS. Our results showed significant difference of baicalin metabolism between RS and SHL. However, baicalein was found to be the main metabolites of baicalin in intestinal tract after oral administration of RS and SHL, glucuronide, glucoside and methylated products were also found in rat urine after administration of either RS or SHL. Meanwhile, several sulphates were found in rat urine after RS administration, but not found after SHL. Among the metabolites of the SHL, potentially there existed a isomerized baicalin and methy- Crud Drug Preparation. Extract of Radix scutellariae Radix scutellariae was cut into slices, decocted with water for 3 times, 2 h for the first time, 1 h for the second and third time respectively, Combined decoctions were filtered, concentrated to a relative density of 1.05-1.10 at 80°C. The pH of the solution was adjust to 1.0-2.0 with 2.0 mol/l hydrochloric acid at 80°C. The temperature was maintained for 1 h and solution was then allowed to stand for 24 h. Precipitate from the filtered solution above was washed with water and pH was adjusted to 5.0. Then solution was further washed with 70% ethanol with pH adjusted to 7.0. The solution was evaporated in a cold vacuum to obtain reserved extract. The content of baicalin was determined to be 78.2% with HPLC.
2)
Shuang-Huang-Lian Extract Radix scutellariae, Flos lonicerae and
Fructus forsythiae were were mixed with 1 : 1 : 2 ratio. Flos lonicerae and Fructus forsythiae were macerated in warm water for 30 min, and decocted for 2 times with 1.5 h for each time. The filtrates from each decoction were combined and concentrated to a thick solution with a relative density of 1.20-1.25 at 70-80°C. When the temperature dropped to 40°C, ethanol was slowly added until ethanol accounted for 75% in the final solution. The well-mixed solution was allowed to stand for 12 h and then filtered to obtain the supernatant. The precipitate was stirred in 75% ethanol and allowed to set for 12 h. This solution was filtered again, combined with the supernatant above and concentrated with a relative density of 1.30-1.32 at 60-65°C. The extract was evaporated in a cold vacuum and combined with extract of RS, as shown above. Animals and Treatments Eighteen male Sprague-Dawley rats (200-250 g) were obtained from Experimental Animal Center of China Pharmaceutical University (Certificate No. 97024). They were divided into two groups randomly and given SHL extract and RS extract orally with a single dose of 400 mg/kg based on the content of baicalin after fast overnight. Feces, Urine and bile were collected before and after drug administration.
Sample Preparation One hundred milligrams dried and smashed feces was mixed with 2 ml methanol-water solution (45 : 55) in vortex, extracted by ultrasonication, and separated by centrifugation (12000 rpm) for 10 min. The supernatant was filtered and analyzed.
Urine and bile were separated by centrifugation (14000 rpm) for 10 min. The upper solution 20 ml was injected and analyzed by LC/DAD/MS.
Results and Discussions
The rat feces, urine and bile samples were analyzed by HPLC/DAD/MS. Multi-stage mass spectrometry using a combination of electrospray ionization with a quadruple ion trap in negative mode was applied to elucidate the structures of metabolites of baicalin in RS and SHL. Having obtained MS1, MS2 and MS3 data, the retention time, molecular weight and significant structural information were obtained from this analysis. Additional structural data were collected from subsequent LC/MS n analysis designed to collect MS n data for specific ions of interest. Chromatograms and MS spectra were illustrated in Figs. 1-3 and Table 1 .
Metabolites of Baicalin in Rat Feces after i.g. RS and i.g. SHL Baicalin was hydrolyzed into baicalein by the rat intestinal bacteria after oral administration of both RS and SHL.
Metabolites of Baicalin in Rat Bile after i.g. SHL and i.g. RS The major metabolites were found in rat bile after oral administration and their chemical structures were identified primarily (Table 1) . were also not found. The present data indicated that metabolites, X1, X2, X3 and X4 were not the derivatives of baicalin.
Metabolites of Baicalin in
According to the above analysis, the following metabolic pathways of baicalin in rat bile can be proposed (Fig. 3) .
Metabolites of Baicalin in Rat Urine after i.g. RS and i.g. SHL Baicalin and its major metabolites baicalin-6-
were found in rat urine after administration of both RS and SHL. However, a probable isomerized baicalin and methylated product, 5,7-dihydroxy-6-methoxyisoflavone-7-O-b-glucopyranuronoside (M5Ј), but no unidentified metabolite M3 was found in rat urine after administration of SHL but not after administration of RS.
The renal clearance rate of bacailin after RS administration was lower than that of bacailin after SHL administration, suggested that other drugs in compound Shuang-Huang-Lian promoted the metabolism of baicalin.
The metabolic pathways of baicalin in rat urine can be proposed as follows (Fig. 5) .
Conclusion
In this study, an LC/DAD/MS experiment was performed on rat feces, urine and bile samples. Metabolites of baicalin of RS and SHL were characterized using multi-stage mass spectrometry in negative ion mode.
The results of the present study demonstrated that the major metabolites of baicalin or baicalein were glucuronide and sulphate after oral administration of the single herb RS, although a small amount of glucoside and methylated products were also found. No sulphated product was found after oral administration of the compound SHL prescription, although the main metabolites of baicalin and baicalein in rat bile were mainly the same. Flavonoid glycosides were considered to be natural prodrugs. 7) Baicalin was transformed to its aglycone baicalein by the intestinal bacteria before absorption, and the metabolites of baicalin were more effective than the parental compound. 6, 7) Our results suggested that other drugs in SHL promoted the metabolism of baicalin, therefore, it could be concluded that SHL might exert more effectiveness than RS.
With the data obtained from this study, it can be concluded that there were significant differences between the metabolites of baicalin after administration of SHL and those of baicalin after administration of RS. These differences indicated that compatibility of medicines could result in the differences of metabolites. This conclusion might give a help to explain the acting mechanism of traditional Chinese compound prescriptions.
